Simplex Trading, LLC Precision Biosciences Inc Transaction History

Simplex Trading, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 02, 2024	BUY	$0.29 - $0.45 $1 - $1	4 Added 4.17%	100 $0
Q3 2023 Nov 01, 2023	BUY	$0.34 - $0.69 $32 - $66	96 New	96 $0
Q4 2022 Feb 02, 2023	SELL	$0.97 - $45.0 $8,242 - $382,365	-8,497 Reduced 35.74%	15,275 $18,000
Q3 2022 Nov 04, 2022	BUY	$1.22 - $40.8 $9,232 - $308,774	7,568 Added 46.7%	23,772 $30,000
Q2 2022 Aug 03, 2022	BUY	$1.15 - $3.34 $15,131 - $43,947	13,158 Added 431.98%	16,204 $25,000
Q1 2022 May 02, 2022	BUY	$2.96 - $7.76 $7,328 - $19,213	2,476 Added 434.39%	3,046 $9,000
Q4 2021 Feb 23, 2022	SELL	$7.4 - $11.66 $36,371 - $57,308	-4,915 Reduced 89.61%	570 $4,000
Q2 2021 Aug 12, 2021	BUY	$8.07 - $12.52 $3,647 - $5,659	452 Added 8.98%	5,485 $68,000
Q1 2021 Apr 26, 2021	SELL	$8.57 - $15.79 $180,235 - $332,079	-21,031 Reduced 80.69%	5,033 $52,000
Q4 2020 Feb 02, 2021	BUY	$5.98 - $12.47 $155,862 - $325,018	26,064 New	26,064 $0
Q2 2020 Jul 13, 2020	SELL	$4.66 - $8.7 $11,724 - $21,889	-2,516 Closed	0 $0
Q1 2020 Apr 29, 2020	BUY	$5.05 - $15.01 $12,705 - $37,765	2,516 New	2,516 $15,000

2.56M

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $584M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.